"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 25 | 3 | 28 |
| 1994 | 34 | 2 | 36 |
| 1995 | 50 | 1 | 51 |
| 1996 | 44 | 7 | 51 |
| 1997 | 41 | 8 | 49 |
| 1998 | 51 | 7 | 58 |
| 1999 | 70 | 7 | 77 |
| 2000 | 57 | 15 | 72 |
| 2001 | 71 | 4 | 75 |
| 2002 | 62 | 11 | 73 |
| 2003 | 113 | 14 | 127 |
| 2004 | 108 | 14 | 122 |
| 2005 | 127 | 12 | 139 |
| 2006 | 130 | 12 | 142 |
| 2007 | 137 | 8 | 145 |
| 2008 | 123 | 10 | 133 |
| 2009 | 108 | 14 | 122 |
| 2010 | 115 | 20 | 135 |
| 2011 | 156 | 21 | 177 |
| 2012 | 120 | 18 | 138 |
| 2013 | 134 | 13 | 147 |
| 2014 | 98 | 16 | 114 |
| 2015 | 104 | 10 | 114 |
| 2016 | 104 | 15 | 119 |
| 2017 | 97 | 15 | 112 |
| 2018 | 70 | 7 | 77 |
| 2019 | 81 | 4 | 85 |
| 2020 | 90 | 4 | 94 |
| 2021 | 78 | 7 | 85 |
| 2022 | 61 | 0 | 61 |
| 2023 | 41 | 0 | 41 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. Epigenetics. 2023 12; 18(1):2180585.
-
Persistent organic pollutants promote aggressiveness in prostate cancer. Oncogene. 2023 Sep; 42(38):2854-2867.
-
A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. Cancer Lett. 2023 09 01; 571:216333.
-
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer. J Exp Clin Cancer Res. 2023 Jul 29; 42(1):187.
-
RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles. Nat Commun. 2023 07 24; 14(1):4445.
-
The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access?to Imaging and Treatment of Metastatic Prostate Cancer. Clin Oncol (R Coll Radiol). 2023 10; 35(10):e628-e635.
-
ProsTAV, a novel blood-based test for biopsy decision management in significant prostate cancer. Prostate. 2023 10; 83(14):1323-1331.
-
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). Eur Urol. 2023 10; 84(4):361-370.
-
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. Oncogene. 2023 08; 42(32):2428-2438.
-
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply. J Urol. 2023 09; 210(3):411-412.